CLINICAL TRIALS PROFILE FOR ERLEADA
✉ Email this page to a colleague
All Clinical Trials for Erleada
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02366494 ↗ | Micro RNAs to Predict Response to Androgen Deprivation Therapy | Active, not recruiting | Medical College of Wisconsin | 2015-04-29 | Identify exosomal micro RNA that predict responses to ADT | |
NCT03009981 ↗ | A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer | Recruiting | Janssen Research & Development, LLC | Phase 3 | 2017-03-06 | This is a randomized, open-label, three-arm, phase 3 study in men with biochemically recurrent prostate cancer and PSA doubling time ≤ 9 months at the time of study entry. |
NCT03009981 ↗ | A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer | Recruiting | Alliance Foundation Trials, LLC. | Phase 3 | 2017-03-06 | This is a randomized, open-label, three-arm, phase 3 study in men with biochemically recurrent prostate cancer and PSA doubling time ≤ 9 months at the time of study entry. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Erleada
Condition Name
Clinical Trial Locations for Erleada
Trials by Country
Clinical Trial Progress for Erleada
Clinical Trial Phase
Clinical Trial Sponsors for Erleada
Sponsor Name